Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

NCT02800148 Phase 3 COMPLETED Results posted

To compare the bioequivalence of Perrigo's azelaic acid foam product to Finacea Foam for the treatment of Inflammatory Lesions of Rosacea

Details

Lead sponsor	Padagis LLC
Phase	Phase 3
Status	COMPLETED
Enrolment	667
Start date	2016-11
Completion	2017-10

Conditions

• Rosacea

Interventions

• Azelaic acid foam
• Azelaic acid foam
• Azelaic acid foam - Placebo

Primary outcomes

• Percent Change (Reduction) of Lesion Count From Day 1 — Day 84

Countries

United States